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Abstract
Objective: Interaction of stromal and tumor cells plays a dynamic role in initiating and enhancing carcinogenesis. In this
study, we investigated the crosstalk between colorectal cancer (CRC) cells with stromal fibroblasts and the anti-cancer
effects of curcumin and 5-Fluorouracil (5-FU), especially on cancer stem cell (CSC) survival in a 3D-co-culture model that
mimics in vivo tumor microenvironment.
Methods: Colon carcinoma cells HCT116 and MRC-5 fibroblasts were co-cultured in a monolayer or high density tumor
microenvironment model in vitro with/without curcumin and/or 5-FU.
Results: Monolayer tumor microenvironment co-cultures supported intensive crosstalk between cancer cells and fibroblasts
and enhanced up-regulation of metastatic active adhesion molecules (b1-integrin, ICAM-1), transforming growth factor-b
signaling molecules (TGF-b3, p-Smad2), proliferation associated proteins (cyclin D1, Ki-67) and epithelial-to-mesenchymal
transition (EMT) factor (vimentin) in HCT116 compared with tumor mono-cultures. High density tumor microenvironment
co-cultures synergistically increased tumor-promoting factors (NF-kB, MMP-13), TGF-b3, favored CSC survival (characterized
by up-regulation of CD133, CD44, ALDH1) and EMT-factors (increased vimentin and Slug, decreased E-cadherin) in HCT116
compared with high density HCT116 mono-cultures. Interestingly, this synergistic crosstalk was even more pronounced in
the presence of 5-FU, but dramatically decreased in the presence of curcumin, inducing biochemical changes to
mesenchymal-epithelial transition (MET), thereby sensitizing CSCs to 5-FU treatment.
Conclusion: Enrichment of CSCs, remarkable activation of tumor-promoting factors and EMT in high density co-culture
highlights that the crosstalk in the tumor microenvironment plays an essential role in tumor development and progression,
and this interaction appears to be mediated at least in part by TGF-b and EMT. Modulation of this synergistic crosstalk by
curcumin might be a potential therapy for CRC and suppress metastasis.
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Introduction
Colorectal cancer (CRC) is the third most common cancer in
the world and poses major clinical problems due to its high
metastasis and recurrence rate [1,2]. Accumulating evidence
suggests that the development and progression of colorectal cancer
is due to genetic and epigenetic alterations that are the result of
complex interactions of transformed cells with their microenvi-
ronment [1,3]. The tumor microenvironment is regarded as the
tumor bed, which comprises of resident components, such as
stromal cells and the factors that are stable within the milieu of the
stroma, and non-resident components such as different immune
cell populations, which influence tumor invasion and metastasis
[4]. The synergistic impact of the microenvironment on inflam-
matory responses and tumor progression is now considered to be
an essential feature of carcinogenesis [1], and there is growing
interest in the identification of agents that specifically target the
pathway interaction between the tumor and stromal cells [5].
It has been proposed that CRC formation arises from a small
sub-population of self-renewing tumor stem cells located within the
colonic crypt [6,7]. Indeed, the CRC stem cells (CSC) exhibit
properties similar to physiologic stem cells and are responsible for
tumor progression [7,8]. Recently, it has been proposed that CSCs
are the unique cell type in the tumor microenvironment that
maintain the microenvironment and enhance cancer metastasis
and invasion [4,9]. Further, it has been shown that CSC can
directly or indirectly interact with several immune cell populations
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within the tumor microenvironment, which are thought to
markedly influence tumor progression [4].
Identifying agents that are able to suppress the crosstalk
between cancer and stromal cells in the tumor microenvironment
might be an important therapeutic target for repressing the
metastatic potential of CSCs. In order to develop new treatment
strategies for CRC, it is therefore essential to study in more detail
the interaction of CSCs with the resident and non-resident
components in their microenvironment to elucidate the detailed
mechanisms by which CRC development and progression is
controlled.
As a large proportion of CRCs are related to environmental
factors [1], nutraceuticals offer themselves as ideal candidates to
modulate the tumor microenvironment and thus support chemo-
therapy. Indeed, this is important as more than 15% of patients
develop resistance to conventional/current chemotherapy with 5-
Fluorouracil (5-FU) and more than 50% of patients develop
relapse [10]. We and others have previously shown that
nutraceuticals, such as curcumin, can directly influence CRC
stem cells by heightening their chemosensitivity to chemothera-
peutic treatment, thus markedly increasing positive therapeutic
outcome [11–13]. Derived from the rhizomes of the plant curcuma
longa, curcumin (diferuloylmethane) is a naturally occurring
yellow polyphenol which mediates its effects by modulation of
several important molecular targets including transcription factors
(NF-kB, AP-1, b-Catenin), enzymes (e.g. Cox-2, MMPs), pro-
inflammatory cytokines (e.g. TNF-a, IL-1b, and IL-6), and cell
surface adhesion molecules (e.g. Cadherins, Integrins) [14–16].
Modulation of matrix metalloproteinase (MMP) expression in the
tumor (micro)-environment is important as MMPs are known
markers for CRC progression [17–19]. Tumor metastasis and
invasion is further influenced by tumor cell interaction with
epithelial and endothelial cells. Adhesion and signaling molecules,
such as integrins play an important role during CRC progression
and metastasis [20,21]. Further, intracellular adhesion molecule-1
(ICAM-1) has been shown to enhance tumor cell proliferation and
invasion and has been identified as being responsible for
endothelial adhesion of cancer cells, thus strongly influencing
metastatic potential [22,23]. The tumor microenvironment
furthermore induces NF-kB activation which is known to regulate
several genes involved in tumor initiation, promotion, and
metastasis [24,25], and induce Wnt activity which plays a critical
role in the biology of CRC stem cells [26].
Transforming growth factor-b (TGF-b) is a multifunctional
polypeptide that plays an essential role in differentiation,
proliferation and embryonic development in normal tissues.
Tissue cells synthetize and secrete TGF-b into the microenviron-
ment where it binds to specific TGF-b receptors for paracrine and
autocrine signalling. This ligand and receptor complex stimulates
intracellular signaling cascades that include the canonical Smad2
signaling pathway [27], which form complexes with Smad4 and
accumulates and translocates into the nucleus. In the nucleus,
activated Smad complexes regulate the transcription of specific
genes and ultimately regulate cell cycle and tissue repair [27]. It is
known that TGF-b is a tumor suppressor in normal tissue cells and
in early stages of tumor progression. In tumor cells the growth
inhibitory effect of TGF-b signalling is dysregulated and it switches
from tumor suppressor to tumor promoting factor in different
organs [27,28]. Moreover, it has been reported that the
stimulation of TGF-b on stromal cells causes secretion of IL-11
and increases the capability of metastasis of CRC cells whereas
animals treated with a specific inhibitor of TGF-b receptor 1 are
resilient to metastasis formation [29]. Interestingly, it has been
reported that secretion of cytokines and growth factors by stromal
cells into a tumor microenvironment triggers an epithelial-to-
mesenchymal transition (EMT) that supports drug resistance,
tumor recurrence, invasion and metastasis of neoplastic cells [30].
Furthermore, E-cadherin expression is down-regulated during
EMT and this can be blocked by zinc finger transcriptional
suppressors, such as Slug and this process is reversible [31–34].
Characterization of molecular mechanisms involved in the
tumor promoting role of TGF-b signaling and EMT in a tumor
microenvironment between fibroblasts and tumor cells can help to
develop therapeutic strategies against tumor development such as
CRC. Therefore, the aim of the presented study was to investigate
in more detail the interaction of CRC cells with stromal
fibroblasts, activation of cancer-promoting inflammation proteins,
paracrine mediators and the modulating effects of curcumin and
5-FU, especially on CRC stem cells and EMT in an in vitro cancer




Monoclonal anti-ALDH1 was obtained from Acris Antibodies
GmbH (Herold, Germany). Monoclonal anti-CD133 and anti-
CD44 were purchased from Abcam PLC (Cambridge, UK). Anti-
b-actin, anti-cyclin-D1, anti-ICAM-1, anti-vimentin, anti-E-cad-
herin, anti-Slug, anti-TGF-b3, anti-TGF-b3R and anti-p-Smad2
were obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Anti-MMP-1, anti-MMP-9 and anti-MMP-13 were pur-
chased from R&D Systems, Inc., (Heidelberg, Germany). Anti-
phospho-specific p65 (NF-kB) and anti-phospho-specific p50 (NF-
kB) were obtained from Cell Technology (Beverly, MA, USA).
Neutralizing pan-TGF-b antibody, normal rabbit IgG and anti-
b1-Integrin were purchased from Sigma-Aldrich Chemie (Mu-
nich, Germany). Anti-Ki-67 and secondary antibodies used for
fluorescence labelling were purchased from Dianova (Hamburg,
Germany). Alkaline phosphatase linked sheep anti-mouse and
sheep anti-rabbit secondary antibodies for immunoblotting were
purchased from Millipore (Schwalbach, Germany).
Growth media, chemicals and cytokines
Growth medium (Ham’s F-12/Dulbecco’s modified Eagle’s
medium (50:50) containing 10% fetal bovine serum (FBS), 25 mg/
ml ascorbic acid, 50 IU/ml streptomycin, 50 IU/ml penicillin,
2.5 mg/ml amphotericin B, essential amino acids and L-gluta-
mine), Trypsin/EDTA (EC 3.4.21.4) were purchased from
Biochrom (Berlin, Germany). 5-FU was purchased from Sigma
(Munich, Germany). BCM-95 curcumin, with a purity greater
than 95% was purchased from Dolcas Biotech LLC (NJ, USA).
This commercial source of curcumin contains three major
components: Diferuloylmethane (the most abundant and active
component of turmeric) (82%) and its derivatives demethoxycur-
cumin (15%) and bisdemethoxycurcumin (3%), together referred
to as curcuminoids [35,36]. Curcumin was dissolved in dimethyl-
sulfoxide (DMSO) as a stock concentration of 5000 mM and stored
at -80uC. Serial dilutions were prepared in culture medium.
100 mM stock of 5-FU (5-Fluorouracil) was prepared in absolute
DMSO and stored at 220uC. The concentration of DMSO was
less than 1% of drug treatment. For treatment, 5-FU was diluted
in DMEM and added to cultures to give the desired final
concentration.
Cell lines and cell culture
Human colon cancer cells (HCT116) and normal human
fibroblast cells (MRC-5) were obtained from the European
Curcumin Blocks Crosstalk between CRC Cells and Fibroblasts
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Collection of Cell Cultures (Salisbury, UK). The cells were
maintained in tissue culture flasks with growth medium in a
humidified incubator at 37uC in an atmosphere of 95% air and
5% CO2. The medium was changed three times a week and cells
passaged when 70% confluency was reached. For monolayer
tumor microenvironment co-cultures, HCT116 and MRC-5 were
co-cultured at a ratio of 1:1 in monolayer culture and the co-
cultures were left for up to 3 days. The supplemented DMEM
media was changed every 3–4 days and cells harvested at the time
points indicated. All co-cultures were seeded at confluency to
ensure optimal contact between the cells. For high density tumor
microenvironment co-cultures, HCT116 high density cultures
were co-cultured with MRC-5 in monolayer. For formation of
high density cultures, a 10ml drop of cell suspension containing
around 1 million HCT116 cells was placed on a nitrocellulose
filter on top of a steelnet bridge, as previously described [37]. In
this system the cells aggregate and are nurtured by diffusion.
MRC-5 cells are grown in monolayer on the bottom of the petri
dish. This model mimics a three dimensional in vivo situation and
allows the exchange between resident components and the cancer
cells in the tumor microenvironment on the air medium
interphase. High density tumor microenvironment co-cultures
were either left untreated or treated with curcumin alone (5mM) or
5-FU alone (1, 5, and 10mM) or were pretreated for 4 h with
curcumin (5mM) followed by treatment with 5-FU (0.1, 1, 2 and
3mM) for the indicated time. In some experiments, to investigate
the role of TGF-b during the crosstalk in the tumor microenvi-
ronment co-cultures, the cultures were treated with a neutralizing
antibody to TGF-b (10, 20, 30 ng/ml) or control IgG (10, 20,
30 ng/ml) for the indicated time.
Indirect immunofluorescence microscopy analysis of
monolayer and high density tumor microenvironment
co-cultures
HCT116 and MRC-5 were co-cultured at a ratio of 1:1 on glass
plates in monolayer or in high density tumor microenvironment
co-cultures. After fixation with methanol for 10 min, cells were
rinsed three times with PBS and overlaid with bovine serum
albumin (BSA) for 30 min. Primary antibodies were diluted 1:50 in
PBS/BSA, incubated overnight at 4uC in a humid chamber,
washed three times with PBS/BSA followed by incubation with
rhodamine-coupled secondary antibodies (diluted 1:80 in PBS/
BSA) for 1 h at ambient temperature and finally washed again
three times with aqua dest. Counter staining was performed with
DAPI (49,6-Diamidino-2-phenylindole, Sigma) to visualize cell
nuclei. Slides were covered with fluoromount mountant and
examined under a fluorescent microscope (Leica, Germany).
Toluidine blue staining of monolayer and high density
tumor microenvironment co-cultures
MRC-5 cells were cultured in monolayer in high density tumor
microenvironment co-cultures with HCT116 cells. High density
tumor microenvironment co-cultures were either left untreated,
treated with curcumin alone (5mM), 5-FU alone (1mM) or were
pretreated for 4 hours with curcumin (5mM) followed by treatment
with 5-FU (0.1, 1, 2, 3 mM). HCT116 and MRC-5 cultures were
evaluated after 10 days. HCT116 high density tumor microenvi-
ronment co-cultures were embedded in Tissue-Tek (Sakura
Finetek Europe, The Netherlands), cryopreserved at 280uC and
cut into 5–7 mm sections using a cryomicrotome (Zeiss, Germany).
Monolayer MRC-5 cells were fixed with methanol for 10 min.
HCT116 sections and MRC-5 monolayers were stained with
toluidine blue and examined under a light microscope (Leica,
Germany).
Uptake of curcumin in monolayer and high density
tumor microenvironment co-cultures
The cellular uptake of curcumin in the monolayer- and high
density co-cultures, as described above, was evaluated with the
fluorescence method. Briefly, for fluorescence examination
HCT116 sections and MRC-5 cultures were fixed with parafor-
maldehyde, covered with fluoromount mountant and examined
under a fluorescent microscope (Leica, Germany).
Western blot analysis
Whole cell lysates of HCT116 high density mono- or co-cultures
were prepared and fractioned by SDS-PAGE [12]. Briefly, cells
were rinsed in PBS, and the proteins were extracted with lysis
buffer (50 mM Tris/HCl (pH 7.2), 150 mM NaCl, 1% (v/v)
Triton X-100, 1 mM sodium orthovanadate, 50 mM sodium
pyrophosphate, 100 mM sodium fluoride, 0.01% (v/v) aprotinin,
pepstatin A (4 mg/ml), leupeptin (10 mg/ml), and 1 mM phenyl-
methylsulfonyl fluoride (PMSF)) for 30 min on ice. After adjusting
the total protein concentration with bicinchoninic acid system
(Pierce) using bovine serum albumin as a standard, equal
quantities (500 mg protein per lane) of total proteins were
separated by SDS-PAGE under reducing conditions. Separated
proteins were transferred to nitrocellulose membranes and
incubated in blocking buffer (5% (w/v) skimmed milk powder in
PBS, 0.1% Tween 20) for 1 h at ambient temperature.
Membranes were incubated overnight with the primary antibody
diluted in blocking buffer at 4uC on a shaker, washed 3 times with
blocking buffer, and then incubated with the secondary antibody
conjugated with alkaline phosphatase for 90 min at room
temperature. Membranes were washed 3 times in 0.1 M Tris
(pH 9.5) containing 0.05 M MgCl2 and 0.1 M NaCl. Specific
antigen-antibody complexes were detected using nitroblue tetra-
zolium and 5-bromo-4-chloro-3-indoylphosphate (p-toluidine salt;
Pierce, Rockford, IL, USA) as substrates for alkaline phosphatase.
Statistical analysis
Numerical data are expressed as the mean values (+/2SD) for a
representative experiment performed in triplicate. The means
were compared using Student’s t test assuming equal variances.
Differences were considered to be statistically significant if the p
value was less than 0.05.
Results
To understand some of the key biological behaviors of stromal
and tumor cells and to simulate an in vivo tumor microenviron-
ment, in vitro co-culture systems were established. The focus of
this study was to investigate the interaction of HCT116 colorectal
cancer cells with human fibroblast MRC-5 cells in a high density
co-culture microenvironment model with or without curcumin
and/or 5-FU on tumor cell proliferation, tumor-promoting
factors, invasion, EMT and colorectal CSCs.
The intensive crosstalk between HCT116 and MRC-5 cells
in the monolayer co-culture microenvironment
influences expression of molecules implicated in
adhesion, invasion and/or proliferation
HCT116 and MRC-5 cells were co-cultured at a ratio of 1:1 for
three days in monolayer and evaluated with light microscopy.
HCT116 cells literally accumulated and clustered around the
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MRC-5 cells searching and establishing close cell-to-cell contact
with the MRC-5 cells in the tumor co-culture (Fig. 1, PC). Next,
we performed immunofluorescence staining of monolayer co-
cultures to investigate whether the observed cellular interaction
leads to functional changes in the cells. HCT116 cells in
monolayer culture or HCT116 and MRC-5 cells in monolayer
co-cultures were labeled with b1-Integrin, ICAM-1, Ki-67, Cyclin
D1, TGF-b3, p-Smad2 and vimentin (Fig. 1,IF). We observed
strong expression of adhesion and metastatic molecules b1-
Integrin, ICAM-1, of active cell cycle proteins Ki-67, Cyclin D1,
of TGF-b3, p-Smad2 and of EMT marker vimentin in HCT116
co-cultures compared to HCT116 mono-culture (Fig. 1). Taken
together, these findings suggest that stromal cell interaction is
crucial in tumor promotion, thereby creating a cellular microen-
vironment which regulates cancer progression.
Curcumin and/or 5-FU strongly affect cell integrity in
high density tumor microenvironment co-cultures
Next, we evaluated high density tumor microenvironment co-
cultures, HCT116 in high density co-cultured with MRC-5 in
monolayer, that mimic the in vivo situation to investigate the
influences of paracrine therapeutic agents on the crosstalk between
the cells and on tumor cell proliferation, tumor-promoting factors,
invasion and the formation of tumor spheres, a prominent feature
of cancer stem cells. Indeed, it has been reported that normal
fibroblast cells are able to induce differentiation of tumor cells such
Figure 1. Intensive crosstalk between CRC and MRC-5 cells in the tumor microenvironment. HCT116 cells (arrows) were either cultured
alone or were co-cultured with MRC-5 cells (*) at a ratio of 1:1 for three days on glass plates in monolayer and fixated with methanol. For
immunolabeling cells were incubated with primary antibodies against b1-Integrin, ICAM-1, Ki-67, cyclin D1, TGF-b3, p-Smad2 and vimentin) followed
by incubation with rhodamine-coupled secondary antibodies and counterstaining with DAPI to visualize cell nuclei. Images shown are representative
of three different experiments. PC: phase contrast; IF: immunofluorescence; Magnification 4006; bar = 30 nm.
doi:10.1371/journal.pone.0107514.g001
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as of a human colon carcinoma cell line [38,39]. The effects of 5-
FU and/or curcumin on cellular integrity and colonosphere
formation in tumor microenvironment cultures were evaluated in
HCT116 cells after 10 days. The cells were treated with different
concentrations of curcumin or 5-FU (0, 0.1, 1, 5 and 10mM) and
colonosphere formation was evaluated by light microscopy as
described in Materials and Methods. The individual IC50 of
curcumin or 5-FU were approximately 5mM or 3.5mM, respec-
tively (p,0.05). To evaluate the effect of combined treatment,
HCT116 cells were pretreated with 5mM curcumin for 4 h and
then co-treated with different concentrations of 5-FU (0, 0.1, 1, 5
and 10mM) for 10 days. Interestingly, pretreatment with curcumin
reduced IC50 values for 5-FU to 0.1mM in HCT116 (p,0.05)
(Fig. 2A). This suggests that curcumin sensitizes HCT116 cells to
5-FU. Further, toluidine blue staining in control cultures showed
that cells formed well developed spheroid colonies during the
culture period (Fig. 2B:a). Treatment of HCT116 cultures with 5-
FU (5mM) or curcumin (5mM) alone or with curcumin and 5-FU
(5mM/0.1mM) was shown to be highly effective in inhibiting
colonosphere formation and enhancing disintegration of high
density tumor spheres compared with the corresponding controls
(Fig. 2B:a). This effect was higher in with curcumin or curcumin/
5-FU treated co-cultures (Fig. 2B:a). Next, we investigated the
cellular uptake of curcumin by HCT116 in tumor microenviron-
ment co-cultures with fluorescent microscopy. The results showed
clearly that curcumin was taken up by all HCT116 cells in
curcumin treated microenvironment co-cultures (Fig. 2B:b). To
investigate, whether the monolayer MRC-5 cells in the microen-
vironment co-cultures survive the treatment with 5-FU, curcumin
or/and 5-FU, we stained the cells with toluidine blue. As shown in
Fig. 2C:a, the MRC-5 cells are well stained which is a sign of
vitality. Furthermore, curcumin was taken up by all MRC-5 cells
in curcumin treated tumor microenvironment co-cultures
(Fig. 2C:b).
Colon CSCs in CRC cell populations are targeted in high
density tumor microenvironment co-cultures by 5-FU,
curcumin and the combined treatment
It has been reported that the tumor microenvironment plays an
essential role in perpetuation of the CSCs promoting affected by
stroma, inflammatory cells, cytokines and growth factors secreted
by the stromal fibroblasts [26,40]. Therefore, we examined the
behavior of CSCs within the CRC cell population, high density
mono-cultures of HCT116 cells were left untreated. Tumor
microenvironment co-cultures of HCT116/MRC-5 cells were
either left untreated, or treated with 5-FU (5mM), curcumin (5mM)
or pretreated with curcumin (5mM) for 4 h and then exposed to 5-
FU (0.1mM) for 10 days. The cultures were subjected to
immunofluorescence labeling with primary antibodies for CSC
marker (CD133). Slight expression of CD133 was detected in basal
control mono-cultures (Fig. 3A). Interestingly, in contrast, CD133
positive cells from the HCT116 cells in microenvironment co-
cultures were higher compared to that in control mono-culture
(Fig. 3A), indicating the important synergistic role of the crosstalk
between HCT116 and MRC-5 cells in supporting tumor
promotion. Furthermore, CD133 positive cells from the
HCT116 cell line population showed significantly increased
survival upon treatment with 5-FU compared with curcumin or/
and 5-FU (Fig. 3A). In the presence of curcumin or/and 5-FU,
they exhibited marked down-regulation of CD133 positive cells
(Fig. 3A and 3B), demonstrating the prominent chemosensitizing
effect of curcumin on CSCs. By quantification, we confirmed that
the number of CD133-labeled cells increased in the HCT116
microenvironment co-cultures compared to control tumor mono-
culture (Fig. 3A), and CD133 positive cells increased in the
surviving cell population upon treatment with 5-FU, but not with
curcumin or the combined treatment (Fig. 3B).
Curcumin has potent chemosensitization effect on colon
cancer stem cells in CRC cell populations in high density
tumor microenvironment co-cultures
Next, CSC markers (CD133, CD44 and ALDH1) expression
was examined for tumor formation capacity and the chemosensi-
tization effect of curcumin on CSC markers in HCT116 3D high
density tumor microenvironment co-cultures. The co-cultures
were either left untreated, treated with curcumin (5mM), 5-FU (1,
5, and 10mM) alone or were pretreated for 4 h with curcumin
(5mM) followed by treatment with 5-FU (0.1, 1, 2, 3mM) for 10
days (Fig. 4). Additionally, in another set of experiments, HCT116
cells were incubated in high density mono-cultures, without
fibroblasts as a basal control. Control high density mono-cultures
of HCT116 showed basal expression of CSC markers (Fig. 4:-
a,b,c). In contrast to this, immunoblotting analysis of whole cell
lysates showed marked up-regulation of CD133, CD44 and
ALDH1 in HCT116 in control and in 5-FU-treated high density
tumor microenvironment co-cultures in a concentration-depen-
dent manner (Fig. 4:a,b,c). However, interestingly pre-treatment
with curcumin followed by treatment with 5-FU significantly
down-regulated CSC marker expression in a concentration-
dependent manner on HCT116 cells in high density tumor co-
cultures (Fig. 4:a,b,c). Densitometric analysis of typical western
blot experiments show down regulation of CSC markers in
HCT116 cells in cultures treated with either 5-FU, curcumin or/
and 5-FU curcumin (Fig. 4:a,b,c). Taken together, these results
indicate that the paracrine interaction between tumor and stromal
cells is crucial in promoting CSCs and that there is a strong
chemosensitizing effect of curcumin on colon CSC in high density
tumor microenvironment co-cultures.
Curcumin and/or 5-FU interfere in the synergistic
crosstalk between CRC-/CSC-cells and fibroblasts in high-
density tumor microenvironment co-cultures
To examine the interaction between CRC-/CSC-cells and
fibroblasts and to evaluate the effect of curcumin and/or 5-FU on
this synergistic crosstalk, on tumor cell proliferation, invasion and
tumor-promoting factors (MMPs, NF-kB) expression in more
detail, we performed western blotting analysis of the high density
tumor microenvironment co-cultures. The co-cultures were either
left untreated or treated as described above (Fig.4). Untreated high
density mono-cultures of HCT116 expressed MMP-13, however
compared to HCT116 high density tumor microenvironment co-
cultures, expression was markedly lower (Fig. 5:a). These results
are in agreement with other studies that expression of MMPs is
known to be up-regulated in the tumor microenvironment [17–
19,41], known to be regulated by transcription factor NF-kB
[36,42]. Treatment of HCT116 high density tumor microenvi-
ronment co-cultures with curcumin down-regulated the expression
of MMP-13 (Fig. 5:a). In contrast, immunoblotting analysis of
HCT116 treated with 5-FU showed marked dose dependent up-
regulation of MMP-13 (Fig. 5:a). The pre-treatment of the
HCT116 tumor microenvironment co-cultures with curcumin
followed by treatment with 5-FU, although it contains only low
concentrations of 5-FU compared to 5-FU treatment alone,
proved to be most effective in down-regulation of the above
mentioned protein in a concentration-dependent manner
(Fig. 5:a). The mechanism involved in curcumin-mediated inhibi-
tion of 5-FU-induced proliferation and metastatic gene products in
Curcumin Blocks Crosstalk between CRC Cells and Fibroblasts
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HCT116 cells, which are regulated by NF-kB was further
examined. Moreover, it has been shown that NF-kB mediates
tumor progression, and the tumor microenvironment is known to
activate NF-kB expression [24,43]. To evaluate whether curcumin
inhibits the 5-FU-induced activation of NF-kB, HCT116 were
probed for the phosphorylated form of the p65/p50 subunits. The
results showed that significantly more activation of p65 subunit
was observed in HCT116 high density tumor microenvironment
co-cultures compared to control HCT116 high density mono-
cultures and 5-FU-induced p65/p50 phosphorylation in a
concentration-dependent manner (Fig. 5:b). Indeed, curcumin
blocked 5-FU-induced phosphorylation of p65/p50 subunits in a
concentration-dependent manner. Interestingly, co-treatment of
the cultures with combinations of the two agents increased these
effects more than each agent by itself (Fig. 5:b). Densitometric
analysis of typical western blot experiments show down regulation
of NF-kB and MMP-13 in HCT116 cells treated with either 5-FU,
curcumin or/and 5-FU (Fig. 5:a,b). Taken together, these data
suggest that fibroblasts promote tumor cells progression in the co-
culture microenvironment, at least in part through NF-kB
pathways and this could be blocked by curcumin, thereby
sensitizing CSCs to 5-FU treatment.
Inhibition of TGF-b3 and TGF-b3R expression in human
colon cancer cells by 5-FU or curcumin in high density
cultures
To further characterize the potential roles of paracrine factors
in the process of the synergistic crosstalk in cancer-stromal cells
interaction, we next examined TGF-b expression in HCT116 to
explore whether TGF-b is involved in enhancing tumor cell
Figure 2. Toxicity of 5-FU, curcumin and the combination treatment on HCT116/MRC-5 cells and cellular uptake of curcumin in
these cells in high density and monolayer tumor microenvironment co-culture. A: Quantification of the number of colonosheres was
achieved by counting the number of spheroid colonies from 10 microscopic fields in the high density microenvironment co-cultures. Cultures were
either left untreated (Co) or were treated with 5-FU (0.1, 1, 5 or 10mM), curcumin (0.1, 1, 5 or 10mM) or were pretreated with curcumin (5mM) for 4 h,
and then exposed to 5-FU (0.1, 1, 5 or 10mM) for 10 days and evaluated by light microscopy. Values were compared with the control and statistically
significant values with p,0.05 were designated by an asterisk (*) and p,0.01 were designated by an asterisk (**). Toluidine blue staining profile (2B/
C, a) and cellular curcumin uptake (2B/C, b) of HCT116 (B) in high density and in MRC-5 (C) in monolayer co-culture. Tumor microenvironment co-
cultures were either left untreated (Co) or were treated with 5-FU (5mM) (5-FU), curcumin (5mM) (Cur) or were pretreated with curcumin (5mM) for 4 h,
and then exposed to 5-FU (0.1mM) (Cur+52FU) for 10 days and evaluated under a light or fluorescent microscope. Images shown are representative
of three independent experiments. F = Filter. (*) = HCT116 colonosheres. Magnification 4B, 4Ca: 200x, 4Cb: 400x; bar = 30 nm.
doi:10.1371/journal.pone.0107514.g002
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Figure 3. Targeting human colon cancer stem cells (CD133 positive cells) with curcumin and/or 5-FU in high density tumor
microenvironment co-culture. A: High density mono-cultures of HCT116 cells were left untreated (A,Co.HD-mono-culture), high density tumor
microenvironment co-culture of HCT116/MRC-5 cells were either left untreated (A,Co.Microenv-HD-Co-culture), or treated with 5-FU (5mM) (A, 5-FU-
Microenv-HD-Co-culture), curcumin (5mM) (A, Cur-Microenv-HD-Co-culture) or pre-treated with curcumin (5mM) for 4 h, and then exposed to 5-FU
(0.1mM) (A, Cur+5FU-Microenv-HD-Co-culture) for 10 days. Immunolabeling was performed with primary antibodies for colon CSC marker (CD133)
followed by incubation with rhodamine-coupled secondary antibodies and counterstaining with DAPI to visualize cell nuclei. Images shown are
representative of three different experiments. Magnification 4006. bar 30 nm. B: To quantify the amount of CD133-positive cells in high density
cultures described above, 100 cells from 15 microscopic fields were counted. The examination was performed in triplicate, and the results are
provided as the mean values with S.D. from three independent experiments. Values were compared with the control and statistically significant
values with p,0.05 were designated by an asterisk (*) and p,0.01 were designated by an asterisk (**).
doi:10.1371/journal.pone.0107514.g003
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proliferation and tumor-promoting factors. The co-cultures were
either left untreated or treated as described above (Fig. 4). The
cultures were subjected to immunofluorescence labeling with
primary antibodies for TGF-b3 and TGF-b3R followed by
incubation with rhodamine- or FITC-coupled secondary antibod-
ies. The expression of TGF-b3 and TGF-b3R was found diffusely
distributed on the round HCT116 cells cultured in basal control
high density mono-cultures (Fig. 6A: a,f). Interestingly, in contrast
to this, expression of TGF-b3 and TGF-b3R in HCT116 cells in
high density tumor microenvironment co-cultures was higher
compared to that in control mono-culture (Fig. 6A: b,g), indicating
the important role of the crosstalk in HCT116 and MRC-5 cells in
co-cultures for tumor promotion. In HCT116 tumor microenvi-
ronment co-cultures treatment with 5-FU slightly up-regulated the
expression of TGF-b3 and concomitantly TGF-b3R (Fig. 6A: c,h).
In contrast, TGF-b3 and TGF-b3R expression in the HCT116
cell population significantly decreased upon treatment with
curcumin or/and 5-FU treatment (Fig. 6A: d-j). These results
suggest that the co-culture of tumor cells and fibroblast cells
stimulates TGF-b expression/activation in fibroblasts and that in
turn activates further the tumor cells. Statistical evaluation, as
shown in Fig. 6B, confirmed the results in Fig. 6A.
The synergistic crosstalk between CRC-cells and
fibroblasts in tumor microenvironment co-cultures is
mediated partially by TGF-b signaling
To further examine TGF-b signaling pathway in CRC cells in
the tumor microenvironment, the co-cultures were either left
untreated or treated as described above (Fig. 4). Immunoblotting
of cell lysates of the HCT116 high density tumor microenviron-
ment co-cultures indicated that more TGF-b3 was expressed
compared with HCT116 from tumor mono-cultures (Fig. 7A), as
seen as broad bands with apparent molecular weights ranging over
25 kDa, which are characteristic of TGF-b3 polypeptide. Treat-
ment of HCT116 with curcumin by itself significantly down-
regulated TGF-b3 protein expression (Fig. 7A). In contrast,
HCT116 treatment with 5-FU dose-dependently up-regulated
production of TGF-b3 protein and this was markedly down-
regulated again through combinational curcumin/5-FU treatment
(Fig. 7A). Next, we investigated whether TGF-b signaling pathway
activation is related to the induction of Smad2 (Fig. 7B) in
HCT116 cells treated as described above. Indeed, several studies
showed that the most important signal transducers for the
transmission of TGF-b intracellular signaling are the Smads with
the ability to propagate signals from the activated receptor
complex to the nucleus [44–46]. Western blot analysis showed that
Smad2 phosphorylation was significantly higher in HCT116
tumor microenvironment co-culture compared with HCT116
high density mono-cultures (Fig. 7B), as seen as broad bands with
apparent molecular weights ranging over 58 kDa, which are
characteristic of p-Smad2 polypeptides. Following curcumin
treatment, significantly less Smad2 phosphorylation was observed,
whereas treatment with 5-FU dose-dependently increased Smad2
(Fig. 7B). Interestingly, with combination curcumin/5-FU treat-
ment Smad2 phosphoylation was inhibited in a dose-dependent
manner. Taken together, these results demonstrate a potential
adaptation and resistance of CRC/CSC cells towards increasing
dosages of 5-FU and clearly demonstrate the positive chemosensi-
tization effect through curcumin to 5-FU by the combinational
treatment. Further, these data demonstrate that canonical TGF-b
signaling cascades are activated upon stimulation of CRC/CSC
cells and stromal fibroblasts in the tumor microenvironment co-
cultures. We next asked whether TGF-b signaling pathway is
pivotal for the process of the synergistic crosstalk in cancer-stromal
cells interaction. High density tumor microenvironment co-
cultures were either left untreated, treated with a neutralizing
pan-TGF-b antibody or control IgG as described in Materials and
Methods for 10 days (Fig. 7C-D). Culturing of stromal cells with
HCT116 cells in high density tumor microenvironment co-
cultures resulted in an increase of TGF-b expression and Smad2
phosphorylation in HCT116 compared to high density tumor
mono-cultures, and this response was considerably blocked by the
neutralizing pan-TGF-b antibody (Fig. 7C-D), but not by control
IgG (not shown). Taken together, these results indicate that tumor
cells in the microenvironment co-cultures, can activate fibroblasts
Figure 4. Curcumin sensitizes colon cancer stem cells to 5-FU in the high density tumor microenvironment co-culture. HCT116 high
density mono-cultures were either left untreated (HCT, Co.) or were co-cultured with MRC-5 in tumor microenvironment. Tumor microenvironment
co-cultures were either left untreated (Co.), treated with curcumin alone (5mM), 5-FU alone (1, 5, and 10mM) or were pretreated for 4 h with curcumin
(5mM) followed by treatment with 5-FU (0.1, 1, 2, 3mM). After 10 days of culture, total cell lysates of HCT116 high density cultures were prepared and
analyzed by western blotting and quantitative densitometry for CSC marker ALDH1 (a), CD133 (b) and CD44 (c). Densitometric evaluation of protein
expression as revealed by western blot analysis was performed in triplicate. Housekeeping protein b-actin served as a loading control in all
experiments. Values were compared to the control and statistically significant values with p,0.05. Significant values are marked with (*).
doi:10.1371/journal.pone.0107514.g004
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to synthetize active TGF-b, as part of a paracrine interaction in
the microenvironment medium that in turn induces tumor cell
activation, promoting progression and expanded metastatic
patterns, increasing thereby the malignancy of the cancer cells.
The intensive crosstalk between HCT116 and MRC-5 cells
induces EMT in tumor microenvironment co-cultures
In order to get further insights into the functional roles of
paracrine factors in the process of the synergistic crosstalk in
relation to EMT [47,48], we have analyzed the expression of
EMT-associated signaling molecules, such as vimentin, E-
cadherin, Slug. The co-cultures were either left untreated or
treated as described above (Fig. 4). Untreated high density mono-
cultures of HCT116 expressed vimentin at markedly lower levels
and higher E-cadherin expression compared to HCT116 high
density tumor microenvironment co-cultures (Fig. 8A-B). Treat-
ment of HCT116 tumor microenvironment co-cultures with
curcumin down-regulated the expression of vimentin, whereas it
increased E-cadherin levels (Fig. 8A-B). In contrast, immunoblot-
ting analysis of HCT116 tumor microenvironment co-cultures
treated with 5-FU showed marked dose dependent up-regulation
of vimentin, but down-regulation of E-cadherin (Fig. 8A-B).
Furthermore, EMT is associated with the development of
increased resistance to chemotherapeutic agents [30]. To address
this issue, we examined whether curcumin can modulate the
expression of 5-FU-induced vimentin or E-cadherin. The
pretreatment of the co-cultures with curcumin followed by
treatment with 5-FU, proved to be most effective in down-
regulation of vimentin or up-regulation of E-cadherin in a
concentration-dependent manner in HCT116 (Fig. 8A-B). The
transcription factor, Slug is associated in transcriptional suppres-
sion of E-cadherin expression and activation of vimentin in the
molecular EMT program [34]. Interestingly, we observed a
significant increase of Slug expression in HCT116 tumor
microenvironment co-cultures compared with HCT116 tumor
mono-cultures and this response was considerably blocked by
curcumin (Fig. 8C). Furthermore, treatment of HCT116 tumor
microenvironment co-cultures with 5-FU induced Slug expression
in a concentration-dependent manner, whereas curcumin blocked
5-FU-induced Slug expression (Fig. 8C). Next, we asked whether
EMT signaling pathway is one of the essential important processes
of the synergistic crosstalk in cancer-stromal cells interaction and
can be specifically influenced by curcumin. High density tumor
microenvironment co-cultures were either left untreated or treated
with curcumin (1, 5, 10, 20 mM) for 10 days (Fig. 8D-F). Culturing
of stromal cells with HCT116 cells in the microenvironment co-
culture resulted in an increase of vimentin and decrease of E-
cadherin expression in HCT116 cells compared to tumor mono-
cultures and the expression of vimentin was considerably inhibited
and concomitantly the expression of E-cadherin increased by
curcumin in a concentration-dependent manner (Fig. 8D-E).
Consistent with the vimentin- and E-cadherin levels in high
density tumor microenvironment co-cultures, we noted that Slug
expression was increased in high density tumor microenvironment
co-culture, whereas Slug expression decreased predominantly by
curcumin in HCT116 in a concentration-dependent manner
(Fig. 8F). Moreover, immunofluorescence microscopy confirmed
the qualitative changes in the different specific EMT-markers
observed in HCT116 cells by western blot analysis of whole-cell
extracts (Fig. 8G-I). Taken together, these results suggest that the
microenvironment co-cultures (Fig. 9) can activate EMT, as one
important functional part of the synergistic crosstalk in cancer-
stromal cells interaction, promoting progression and expanded
metastatic patterns in the microenvironment and inhibition of this
interaction by curcumin induces biochemical and functional
changes towards MET, thereby sensitizing CSCs to 5-FU
treatment.
Discussion
The aim of this study was to investigate the effect of curcumin
and/or 5-FU on CRC cell proliferation, tumor-promoting factors,
EMT and cancer stem cells in an in vitro two- and three-
dimensional tumor microenvironment co-culture model that
mimics in vivo functions of CRCs/fibroblast tumor microenvi-
ronment interaction.
A large body of literature indicates that, crosstalk in the tumor
microenvironment between cancer and stromal cells can promote
survival, proliferation, malignant behavior of tumor cells and their
ability to develop drug resistance [49–51]. In this study, we firstly
evaluated the crosstalk between HCT116 and MRC-5 cells in
monolayer co-cultures. A dynamic interaction occurred between
two cells, and CRC cells proliferated around the fibroblasts,
searching and establishing close cell-cell contact. Furthermore, we
found that this direct interaction in the co-cultures stimulated the
Figure 5. Effects of 5-FU, curcumin and the combinational treatment on proliferation-, metastatic gene products and NF-kB
expression in the high density tumor microenvironment co-culture. HCT116 high density mono-cultures were either left untreated (HCT,
Co.) or were co-cultured with MRC-5 in monolayer. Tumor microenvironment co-cultures were either left untreated (Co.), treated with curcumin alone
(5mM), 5-FU alone (1, 5, and 10mM) or were pretreated for 4 h with curcumin (5mM) followed by treatment with 5-FU (0.1, 1, 2, 3mM). After 10 days of
culture, total cell lysates of HCT116 high density cultures were prepared and analyzed by western blotting and quantitative densitometry for MMP-13
(a) and NF-kB (b). Densitometric evaluation of protein expression as revealed by western blot analysis was performed in triplicate. Housekeeping
protein b-actin served as a loading control in all experiments. Values were compared to the control and statistically significant values with p,0.05.
Significant values are marked with (*).
doi:10.1371/journal.pone.0107514.g005
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cells to enhance the promotion of metastatic adhesion molecules
(b1-integrin, ICAM-1), proliferative proteins (cyclin D1, Ki-67),
TGF-b3, p-Smad2 and vimentin, suggesting a dynamic interaction
between the two cell types in the tumor microenvironment. Our
findings correlate with results from other groups that have
previously demonstrated that tumor cell and stromal cell crosstalk
Figure 6. Curcumin or 5-FU suppresses TGF-b3 and TGF-bR expression in CRC cells in high density tumor microenvironment co-
culture. A: High density mono-cultures of HCT116 cells were left untreated, high density tumor microenvironment co-cultures of HCT116/MRC-5
cells were either left untreated, or treated with 5-FU (5mM), or with curcumin (5mM) or pre-treated with curcumin (5mM) for 4 h, and then exposed to
5-FU (0.1mM) for 10 days. The cultures were subjected to immunofluorescence labeling with primary antibodies for TGF-b3 (a-e) and TGF-b3R (f-j)
followed by incubation with rhodamine- or FITC-coupled secondary antibodies. Images shown are representative of three different experiments.
Magnification 4006. bar 30 nm. B: To quantify the amount of TGF-b3 and TGF-bR-positive cells in high density cultures described above, 200 cells
from 15 microscopic fields within the stained slides were counted. The results are provided as the mean values with S.D. from three independent
experiments. Values were compared with the control and statistically significant values with p,0.05 were designated by an asterisk (*) and p,0.01
were designated by an asterisk (**).
doi:10.1371/journal.pone.0107514.g006
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plays an important role in the initiation and promotion of cancer
by secreting and exchanging cytokines and growth factors in the
tumor microenvironment [39,52,53].
We next examined the crosstalk between CRCs and fibroblasts
by indirect high density co-culture experiments that mimic the
interaction between these cells in the tumor microenvironment in
vivo (Fig. 9). In these co-culture experiments CRCs formed well
defined high density tumor spheres and treatment with 5-FU and/
or curcumin resulted in high cellular curcumin uptake and
colonosphere disintegration. These results are in accordance with
results from previous studies from our laboratory [12,37], and
others [11,13] demonstrating the anti-tumor activity of curcumin
and the chemosensitizing effect of curcumin in combination with
5-FU on CRC cells. Moreover it has been reported that curcumin
exhibits synergistic activity with 5-FU also in other tumor cells
[54,55].
Next, we found with immunofluorescence evaluation that
expression of stem cell marker (CD133) markedly increased in
HCT116 in high density microenvironment co-cultures compared
to HCT116 high density mono-cultures. This underlines the above
findings, that the tumor microenvironment is a dominant factor
that stimulates and supports formation of tumor stem cells.
Simultaneously we could show that treatment with 5-FU and/or
curcumin inhibited and even diminished stem cell marker
expression in HCT116. As CSCs are believed to be mainly
responsible for treatment resistance, treatment failure and tumor
recurrence [6,56,57], this demonstrates that for new treatment
approaches attention should be turned on targeting specifically the
interaction of the microenvironment and the colon CSCs.
The promising results from the immunofluorescence led us to
investigate more specifically signaling proteins, which influence the
interactions in tumor microenvironment co-cultures, according to
the regulation of tumor promoting inflammation factors and CSC
marker in CRCs. In accordance with the consideration that the
cells of the tumor stroma are a key determinant in tumor
promotion [58], we found that tumor microenvironment co-
cultures produced strikingly higher amounts of invasion related
proteinase (MMP-13), had markedly higher activation levels of
NF-kB compared to CRC high density mono-cultures and
significant up-regulation of CSC markers expression. These results
underline the importance of paracrine interaction between tumor
and stromal cells as a crucial determinant of tumor progression,
invasion and metastasis. Indeed, it has been reported that in the
tumor microenvironment between the tumor and stroma para-
Figure 7. Curcumin, 5-FU and the combinational treatment suppress TGF-b-mediated synergistic crosstalk between CRC-cells and
fibroblasts in tumor microenvironment co-cultures. A-B: HCT116 high density mono-cultures were either left untreated (HCT, Co.) or were co-
cultured with MRC-5 in monolayer. Tumor microenvironment co-cultures were either left untreated (Co.), treated with curcumin alone (5mM), 5-FU
alone (1, 5, and 10mM) or were pretreated for 4 h with curcumin (5mM) followed by treatment with 5-FU (0.1, 1, 2, 3mM). After 10 days of culture, total
cell lysates of HCT116 high density cultures were prepared and immunoblotting performed for TGF-b3 (A) or p-Smad2 (B). C-D: HCT116 high density
mono-cultures were either left untreated (HCT, Co.) or were co-cultured with MRC-5 in monolayer. Tumor microenvironment co-cultures were either
left untreated (Co.) or treated with neutralizing pan-TGF-b antibody (10, 20, 30 ng/ml). After 10 days of culture, total cell lysates of HCT116 high
density cultures were prepared and immunoblotting performed for TGF-b3 (C) or p-Smad2 (D). Densitometric evaluation of protein expression as
revealed by western blot analysis was performed in triplicate. Housekeeping protein b-actin served as a loading control in all experiments. Values
were compared to the control and statistically significant values with p,0.05. Significant values are marked with (*).
doi:10.1371/journal.pone.0107514.g007
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Figure 8. High density tumor microenvironment co-cultures induce EMT with loss of epithelial markers and increase of
mesenchymal markers. A-C: HCT116 high density mono-cultures were either left untreated (HCT, Co.) or were co-cultured with MRC-5 in
monolayer. Tumor microenvironment co-cultures were either left untreated (Co.), treated with curcumin alone (5mM), 5-FU alone (1, 5, and 10mM) or
were pretreated for 4 h with curcumin (5mM) followed by treatment with 5-FU (0.1, 1, 2, 3mM). After 10 days of culture, total cell lysates of HCT116
high density cultures were prepared and immunoblotting performed for vimentin (A) or E-cadherin (B) or Slug (C). D-I: HCT116 high density mono-
cultures were either left untreated (HCT, Co.) or were co-cultured with MRC-5 in monolayer. Tumor microenvironment co-cultures were either left
untreated (Co.), or treated with curcumin (1, 5, 10, 20 mM). After 10 days of culture, total cell lysates of HCT116 HD-cultures were prepared for
immunoblotting (D-F) or immunofluorescence performed on sections (G-I) for vimentin (D, G) or E-cadherin (E, H) or Slug (F, I). Densitometric
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crine and autocrine communications play an important role,
increasing the invasion and metastasis potential in tumor cells [58–
60]. Interestingly, substantial production of tumor promoting
factor (MMP-13) and marked levels of NF-kB were further
pronounced in the presence of 5-FU. Moreover, many different
tumor cells activate constitutive inducible anti-apoptotic NF-kB
for their survival [43,61]. This result seems to be paradox at first,
as 5-FU would be expected to impede tumor promotion.
However, taken into consideration that 5-FU also stimulated
enrichment of CSC marker positive cells in high density tumor
microenvironment co-cultures, these results might be regarded as
a defense reaction/response of the tumor cell culture and the
tumor microenvironment. In fact, it has been reported that in
contrast to the differentiated population of tumor cells, cancer
stem cells are characterized by increased resistance to cytotoxic
chemotherapeutic agents [62], enhanced ability to form colono-
spheres [6,13,63] and induce remission, providing basis for why
cancer cells cannot be completely destroyed by conventional
chemotherapeutic agents [57,64]. Indeed, we could further show
that combinational treatment of curcumin and 5-FU dramatically
suppressed tumor promoting factors, activation of NF-kB signaling
pathway and enrichment of CSCs in high density tumor
microenvironment co-cultures. These results demonstrate once
more the potent chemosensitizing effect of curcumin on CRC, and
to our knowledge show for the first time the modulating effect of
curcumin on the crosstalk between the CRC/CSCs and the
fibroblasts in the tumor microenvironment, creating an adequate
climate for more effective chemotherapeutic action of 5-FU to
specifically target chemoresistant colorectal stem cells.
It seems that for prevention and treatment of tumor develop-
ment, it is important to find factors supporting cancer microen-
vironment. We found in the present study either in monolayer or
in high density tumor co-cultures that the intensive crosstalk in the
tumor microenvironment co-cultures increased TGF-b3 and p-
Smad2 levels in HCT116 cells compared to mono-cultures,
indicating active TGF-b signaling in these cells in the tumor
microenvironment. Moreover, expression of TGF-b and phos-
phorylation of Smad2 was significantly decreased by treatment
with curcumin. To see that TGF-b secretion as one possible
paracrine factor plays an important role in the microenvironment
co-culture, the expression of TGF-b and phosphorylation of
nuclear p-Smad2 could be significantly inhibited by neutralizing
pan-TGF-b antibody, indicating a strong TGF-b dependency.
Interestingly, it has been reported that TGF-b activates NF-kB
and NF-kB-dependent inflammatory proteins in tumor cells [45].
These results are in agreement with other studies showing that
TGF-b is the most prominent of the paracrine factors within the
tumor microenvironment [65,66].
Several lines of evidence have shown that tumor-associated
fibroblasts, inflammatory cells, cytokines and EMT in tumor
biology are potential factors that enable cancer cell invasion,
metastasis and malignancy and this process is reversible [47,67].
Tumor cells have a diversity of phenotypes, malignancy and they
lose their epithelial properties during EMT development [30]. It
has been reported that EMT is a triggering factor for tumor stem
cell formation [68]. Furthermore, as observed, EMT is identified/
characterized by the loss of epithelial properties, including down
regulation of cell adhesion molecules like E-cadherin and at the
same time promoting of N-cadherin, vimentin, fibronectin, zinc-
finger proteins (SNAIL, Slug, ZEB) and matrix metalloproteinases
(MMPs) expression, conducting the tumor cells to an higher cell
mobility and malignity [48]. Moreover, It has been reported that
the EMT-inducing factors, such as TGF-b, PI3K/AKT- and Wnt-
signaling [69,70] produced by the surrounding tumor microenvi-
ronment stromal cells [47] can influence the behavior and invasive
phenotype in epithelial malignancies initiating of tumor cells. Our
results in this study show that tumor microenvironment co-culture
increased EMT markers, such as vimentin, slug and decreased E-
cadherin in HCT116 cells compared to mono-cultures, indicating
the high density tumor microenvironment co-cultures induces
EMT. Expression of vimentin and slug was significantly decreased
and E-cadherin was significantly increased by treatment with
curcumin. Consistent with these results, it has been reported that
MMPs or cytokines, which are secreted by TGF-b-stimulated
stromal cells, initiate GP130/STAT3 and NF-kB signaling in
cancer cells at early time points of the metastatic process and this
crosstalk allows a tumor promoting microenvironment surviving
metastatic tumor cells [29]. Indeed, both signaling pathways, NF-
kB and TGF-b3, can also be activated by direct interactions
between cancer cells and platelets and were found to promote
EMT and metastasis [71]. Several studies have shown that in
cancer an increase of mesenchymal characteristics (N-cadherin
and vimentin) and loss of epithelial characteristics (E-cadherin) via
EMT is proportional with cancer progression, motility, invasive-
ness, drug resistance and metastasis [72–75]. Thus, targeting EMT
and inhibition of cancer stem cells may be a promising strategy to
suppress metastasis and improve survival of cancer patients. Other
different factors secreted by fibroblasts/tumor cells might also
influence TGF-b effects on tumor cells differentiation in micro-
environment co-culture, as has been shown for interleukin-1
[76,77].
evaluation of protein expression as revealed by western blot analysis was performed in triplicate. Housekeeping protein b-actin served as a loading
control in all experiments. Values were compared to the control and statistically significant values with p,0.05. Significant values are marked with (*).
F = Filter. (.) = HCT116 cells. Magnification G-I: 2006, bar = 30 nm.
doi:10.1371/journal.pone.0107514.g008
Figure 9. Schematic demonstrating the crosstalk between CRC-
cells and fibroblasts in high density tumor microenvironment
co-cultures. A 10ml drop of cell suspension containing around 1
million HCT116 cells is placed on a nitrocellulose filter on top of a
steelnet bridge and the cells are nurtured by diffusion. MRC-5 cells are
grown in monolayer on the bottom of the petri dish. This model mimics
a three dimensional in vivo situation and allows the exchange between
resident components and the cancer cells in the tumor microenviron-
ment on the air medium interphase. Addition of therapeutic agents
such as curcumin, 5-FU or neutralizing pan-TGF-b3 antibody can
interact and influence cell signaling in both cell types influencing tumor
cell and tumor stem cell proliferation, malignity and EMT.
doi:10.1371/journal.pone.0107514.g009
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In conclusion, interaction between tumor cells and fibroblasts
occur either direct or paracrine and thereby create a complex
cellular tumor microenvironment (Fig. 9) regulating CSC promo-
tion, their progeny and finally invasion and metastasis activity.
The simultaneous targeting of pathways that regulate interaction
of cell types resident in the tumor microenvironment and the
colorectal CSC might eventually improve the efficacy of thera-
peutic outcome. The tumor microenvironment induces in the cells
invasive properties through up-regulation of NF-kB, TGF-b,
EMT, creating a tumor microenvironment feedback loop (Fig. 9).
In this study, we could emphasize that the natural NF-kB inhibitor
curcumin is a promising modulator of the synergistic crosstalk in
the tumor microenvironment and curcumin-based anti-EMT and
tumor progression may be a promising therapeutic strategy to
prevent resistance to chemotherapeutic agents, sensitizing CSCs to
5-FU and impede metastasis formation.
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